ES8401983A1 - Procedimiento para la preparacion de inmunoglobulina administrable por via intravenosa. - Google Patents

Procedimiento para la preparacion de inmunoglobulina administrable por via intravenosa.

Info

Publication number
ES8401983A1
ES8401983A1 ES518181A ES518181A ES8401983A1 ES 8401983 A1 ES8401983 A1 ES 8401983A1 ES 518181 A ES518181 A ES 518181A ES 518181 A ES518181 A ES 518181A ES 8401983 A1 ES8401983 A1 ES 8401983A1
Authority
ES
Spain
Prior art keywords
preparation
human
intravenously administrable
human immunoglobuline
immunoglobuline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES518181A
Other languages
English (en)
Spanish (es)
Other versions
ES518181A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4194125&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8401983(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten filed Critical Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Publication of ES518181A0 publication Critical patent/ES518181A0/es
Publication of ES8401983A1 publication Critical patent/ES8401983A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES518181A 1982-02-08 1982-12-14 Procedimiento para la preparacion de inmunoglobulina administrable por via intravenosa. Expired ES8401983A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH74182 1982-02-08

Publications (2)

Publication Number Publication Date
ES518181A0 ES518181A0 (es) 1984-01-16
ES8401983A1 true ES8401983A1 (es) 1984-01-16

Family

ID=4194125

Family Applications (1)

Application Number Title Priority Date Filing Date
ES518181A Expired ES8401983A1 (es) 1982-02-08 1982-12-14 Procedimiento para la preparacion de inmunoglobulina administrable por via intravenosa.

Country Status (12)

Country Link
EP (1) EP0085747B2 (enExample)
JP (1) JPS58159424A (enExample)
AR (1) AR229486A1 (enExample)
AT (1) ATE19735T1 (enExample)
AU (1) AU554817B2 (enExample)
DE (1) DE3271181D1 (enExample)
DK (1) DK157367C (enExample)
ES (1) ES8401983A1 (enExample)
FI (1) FI73597C (enExample)
PH (1) PH20924A (enExample)
PT (1) PT75979B (enExample)
ZA (1) ZA828687B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法
DE3382394D1 (de) * 1982-08-30 1991-10-02 Baxter Travenol Lab Verfahren zur herstellung von gamma-globulin enthaltenden zusammensetzungen.
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
AT389817B (de) * 1987-01-22 1990-02-12 Schwab & Co Ges Mbh Verfahren zur herstellung eines in fluessiger form stabilen immunglobulins zur intravenoesen anwendung
EP0318081B1 (en) * 1987-11-27 1991-07-24 Akzo N.V. Stabilization of antibodies
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JPH0778025B2 (ja) * 1990-03-20 1995-08-23 日本赤十字社 免疫グロブリンｇの製造方法
US5256771A (en) * 1990-04-03 1993-10-26 Miles Inc. Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation
DE59309332D1 (de) * 1993-12-27 1999-03-04 Rotkreuzstiftung Zentratrallab Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
RU2128509C1 (ru) * 1996-07-08 1999-04-10 Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского Способ получения субкомпонента c1g комплемента человека
RU2178309C2 (ru) * 2000-01-12 2002-01-20 Российский научно-исследовательский институт геронтологии Антитимоцитарный глобулин для внутривенного введения и способ его получения
TWI391399B (zh) * 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
DE2527064C3 (de) * 1975-06-18 1979-11-15 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
DE2837168A1 (de) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
JPS5625114A (en) * 1979-08-07 1981-03-10 Green Cross Corp:The Preparation of human gamma globulin
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法

Also Published As

Publication number Publication date
DK26583A (da) 1983-08-09
JPH0365327B2 (enExample) 1991-10-11
FI824283L (fi) 1983-08-09
PT75979A (de) 1983-01-01
DK26583D0 (da) 1983-01-24
ZA828687B (en) 1983-09-28
EP0085747B1 (de) 1986-05-14
AR229486A1 (es) 1983-08-31
EP0085747B2 (de) 1990-05-30
PT75979B (de) 1985-10-04
FI73597B (fi) 1987-07-31
ATE19735T1 (de) 1986-05-15
FI73597C (fi) 1987-11-09
EP0085747A2 (de) 1983-08-17
ES518181A0 (es) 1984-01-16
EP0085747A3 (en) 1984-09-05
AU9132882A (en) 1983-08-18
DK157367C (da) 1990-05-21
PH20924A (en) 1987-06-05
JPS58159424A (ja) 1983-09-21
DE3271181D1 (en) 1986-06-19
AU554817B2 (en) 1986-09-04
FI824283A0 (fi) 1982-12-14
DK157367B (da) 1989-12-27

Similar Documents

Publication Publication Date Title
AU549204B2 (en) Intravenously injectable immune serum globulin
GR3029683T3 (en) CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS.
AU1343783A (en) Determination of low density lipoproteins
GB1508050A (en) Bovine milk products
EG15882A (en) Procede de preparation de nouveaux conjuges associants,par liaison covalente,une enzyme et un anticorps
GB1356229A (en) Method for isolation of antithrombin from animal material
GB2128630A (en) Method of affinity purification employing monoclonal antibodies
IL93118A0 (en) Expression vectors,cells transformed thereby and their use in the production of chimeric monoclonal antibodies
IL72985A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
EP0413188A3 (en) Unmodified intravenous igm- and/or iga-containing immunoglobulin preparation and process therefor
HU9202214D0 (en) Medical preparative containing antigen-antibody complexes and its utilization
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
AU7921787A (en) Monoclonal antibodies to omega-interferons
DE2964386D1 (en) Therapeutic means for immune complex diseases
EP0215131A4 (en) ANTIGEN E87Ag OF PSEUDOMONAS AERUGINOSE, MONOCLONAL ANTIBODIES AGAINST THIS ANTIGEN AND HYBRIDOMA.
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
GB1377101A (en) Purification of gamma globulin
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
GR3015489T3 (en) Monoclonal antibodies and process for the diagnosis of phytophtora infections.
COPELAND et al. Coexistence of neurofibromatosis and Marfan's syndrome
GB2146998B (en) Immune interferon and method for its purification
AU582129B2 (en) Circulating antigens of dirofilaria immitis,monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
ES8200701A1 (es) Procedimiento de disminuir el contenido de fenilalanina de los hidrolizados de proteinas y similares
ZA831050B (en) Antibodies and antigens useful in the diagnosis and treatment of cancer
ZW4783A1 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer